Lorena Raquel Lerner insider trades

Open-market stock purchases and sales by Lorena Raquel Lerner, Chief Scientific Officer at Keros Therapeutics, Inc, from SEC Form 4 filings since Feb 18, 2026.

Recent trades

DateStockTradeValue
Aug 18, 2026KROS Keros Therapeutics, IncSold$36.7K
Feb 24, 2026KROS Keros Therapeutics, IncBought (not open market)—
Feb 18, 2026KROS Keros Therapeutics, IncSold$63.3K

Companies traded

  • KROS Keros Therapeutics, Inc: 2 sales, last Aug 18, 2026

Get free alerts when Lorena Raquel Lerner files a new trade →